Regencell Bioscience Holdings Limited
RGC
Kedudukan dalam Saham
#3298
Regencell Bioscience Holdings Limited is a biotechnology firm specializing in... Regencell Bioscience Holdings Limited is a biotechnology firm specializing in Traditional Chinese Medicine (TCM). Its core activities revolve around the research, development, and market introduction of TCM solutions specifically designed to address neurocognitive disorders and related degeneration. The company places a particular emphasis on conditions such as attention deficit hyperactivity disorder (ADHD) and autism spectrum disorder (ASD). Established in 2014, Regencell Bioscience maintains its primary office in Causeway Bay, Hong Kong.
Harga Saham
$10.64
Disegerakkan terakhir: 2026-10-21
Modal Pasaran
$5.28B
Perubahan (1 hari)
1.82%
Perubahan (1 tahun)
-32.44%
Negara
HK
Perdagangan Regencell Bioscience Holdings Limited (RGC)
Kategori
Healthcare
Sejarah harga saham bagi Regencell Bioscience Holdings Limited (RGC)
Harga penutupan tertinggi: $8.23 pada 2026-10-01
Harga penutupan terendah: $0.24 pada 2021-07-01
Harga penutupan terendah: $0.24 pada 2021-07-01
Sejarah harga saham Regencell Bioscience Holdings Limited dari 2021 hingga 2026
Prestasi harga saham tahunan
| Tahun | Prestasi |
|---|---|
| 2026 (TTM) | -1.61% |
| 2025 | 13,046.47% |
| 2024 | -47.20% |
| 2023 | -66.01% |
| 2022 | 8.50% |
| 2021 | 0.00% |
Harga saham bagi syarikat atau pesaing serupa
| Syarikat | Harga saham | Perubahan 1thn% | Negara |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $164.18 | 22.78% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $223.65 | 30.61% |
CH
|
|
| $18.43 | -4.03% |
IN
|
